Ajumobi Olufemi, Friedman Sarah, Westhoff John, Granner Michelle, Lucero Julie, Koch Brandon, Wagner Karla D
School of Public Health University of Nevada Reno Nevada USA.
North Carolina Department of Health and Human Services Raleigh North Carolina USA.
J Am Coll Emerg Physicians Open. 2024 Sep 6;5(5):e13272. doi: 10.1002/emp2.13272. eCollection 2024 Oct.
We described age, gender, race, and ethnicity associations with filling buprenorphine prescriptions post-emergency department (post-ED) visits.
We analyzed 1.5 years (July 1, 2020-December 31, 2021) of encounter-level Medicaid ED and retail pharmacy claims data obtained from the Nevada Department of Health and Human Services. We studied ED patients with an opioid use disorder (OUD) diagnosis who did not fill a prescription for OUD medications within 6 months before the ED encounter. Using logistic regression, we modeled the associations between the patient's demographic characteristics and the outcome, filling a buprenorphine prescription at a community pharmacy within 14 or 30 days of the ED encounter.
Among 2781 ED visits, representing 2094 patients, the median age was 39 years, 54% were male, 18.5% were Black, 11.7% were Hispanic, and 62.3% were White. Only 4% of the ED visits were followed by a filled buprenorphine prescription. Increasing age (14-day window: adjusted odds ratio (aOR) = 0.965, 95% confidence interval [CI]: 0.948-0.983) and being a Black patient (14-day window: aOR: 0.114, 95% CI 0.036-0.361) were both associated with lower odds of filled buprenorphine prescriptions. These results were similar within 30 days of an ED visit.
Initiation of buprenorphine following an ED visit remains low among Nevadan Medicaid patients and is less likely with increasing age and among Black patients, despite strong evidence supporting its use. Overburdened EDs, lack of attention from managers, and substance use stigma are among possible explanations. When ED clinicians do write buprenorphine prescriptions, peer recovery support could increase the fill rates.
我们描述了急诊科就诊后开具丁丙诺啡处方与年龄、性别、种族和族裔之间的关联。
我们分析了从内华达州卫生与公众服务部获取的1.5年(2020年7月1日至2021年12月31日)的急诊医疗补助和零售药房就诊级别索赔数据。我们研究了在急诊科就诊前6个月内未开具阿片类药物使用障碍(OUD)药物处方且被诊断为患有OUD的急诊科患者。使用逻辑回归,我们建立了患者人口统计学特征与结果之间的关联模型,即患者在急诊科就诊后14天或30天内在社区药房开具丁丙诺啡处方。
在代表2094名患者的2781次急诊科就诊中,中位年龄为39岁,54%为男性,18.5%为黑人,11.7%为西班牙裔,62.3%为白人。只有4%的急诊科就诊后开具了丁丙诺啡处方。年龄增加(14天窗口期:调整后的优势比[aOR]=0.965,95%置信区间[CI]:0.948 - 0.983)和黑人患者(14天窗口期:aOR:0.114,95%CI 0.036 - 0.361)均与开具丁丙诺啡处方的较低几率相关。在急诊科就诊后30天内,这些结果相似。
在内华达州医疗补助患者中,急诊科就诊后开始使用丁丙诺啡的比例仍然很低,并且随着年龄增长以及在黑人患者中可能性更小,尽管有强有力的证据支持其使用。急诊科负担过重、管理人员缺乏关注以及药物使用污名化都是可能的解释。当急诊科临床医生开具丁丙诺啡处方时,同伴康复支持可能会提高配药率。